Coding Ahead
CasePilot
Medical Coding Assistant
Case2Code
Search and Code Lookup Tool
CareerCenter
Medical Coding Job Board
Log in Register free account

Need help choosing the right code?

Ask CasePilot about procedures, modifiers, bundling, and coding guidance.

Try CasePilot

Official Description

Hydroxyprogesterone, 20-

© Copyright 2026 American Medical Association. All rights reserved.

Common Language Description

The CPT® Code 83499 refers to a laboratory test that measures the level of 20-alpha (20α) hydroxyprogesterone, which is an inactive metabolite of the hormone progesterone. Progesterone plays a crucial role in reproductive health, particularly in conception and the maintenance of pregnancy. The conversion of progesterone to 20α-hydroxyprogesterone is facilitated by the enzyme 20 hydroxysteroid dehydrogenase (20α-HSD). Monitoring the levels of 20α-hydroxyprogesterone is important because an imbalance between active progesterone and its inactive form can lead to various reproductive issues, including infertility, miscarriage, and preterm labor. To perform this test, a blood sample is collected through a procedure known as venipuncture, which is separately reportable. The serum obtained from the blood sample is then analyzed using a radioimmune assay, a sensitive technique that allows for the precise measurement of hormone levels in the bloodstream.

© Copyright 2026 Coding Ahead. All rights reserved.

1. Indications

The laboratory test for 20-alpha (20α) hydroxyprogesterone is indicated for the evaluation of various reproductive health issues. The following conditions may warrant this test:

  • Infertility The test may be performed to assess hormonal imbalances that could be contributing to difficulties in conceiving.
  • Miscarriage Measuring 20α-hydroxyprogesterone levels can help determine if hormonal deficiencies are a factor in recurrent pregnancy loss.
  • Preterm Labor The test may be utilized to evaluate the hormonal status of a patient experiencing signs of preterm labor, aiding in the management of the pregnancy.

2. Procedure

The procedure for measuring 20-alpha (20α) hydroxyprogesterone involves several key steps that ensure accurate results. First, a healthcare professional will prepare the patient for venipuncture, which is the process of drawing blood from a vein. This may involve cleaning the skin with an antiseptic to reduce the risk of infection. Once the site is prepared, a tourniquet may be applied to the upper arm to engorge the veins, making them more visible and easier to puncture. A sterile needle is then inserted into the vein, and blood is drawn into a collection tube. After the required amount of blood is collected, the needle is removed, and pressure is applied to the puncture site to minimize bleeding. The collected blood sample is then labeled and sent to the laboratory for analysis. In the lab, the serum is separated from the blood cells and tested using a radioimmune assay, which is a highly sensitive method for quantifying hormone levels. This assay allows for the precise measurement of 20α-hydroxyprogesterone, providing valuable information for the clinician regarding the patient's hormonal status.

3. Post-Procedure

After the venipuncture procedure, patients may experience minor discomfort or bruising at the site of the blood draw, which typically resolves on its own. It is advisable for patients to keep the bandage on the puncture site for a few hours to prevent any bleeding. There are generally no specific restrictions following the test, and patients can resume their normal activities immediately. However, if there are any unusual symptoms, such as excessive bleeding or signs of infection, patients should contact their healthcare provider for further evaluation. The results of the 20α-hydroxyprogesterone test will be interpreted by the physician in conjunction with the patient's clinical history and other diagnostic tests to determine the appropriate course of action.

Short Descr ASSAY OF PROGESTERONE 20-
Medium Descr ASSAY OF HYDROXYPROGESTERONE 20-
Long Descr Hydroxyprogesterone, 20-
Status Code Statutory Exclusion (from MPFS, may be paid under other methodologies)
Global Days XXX - Global Concept Does Not Apply
PC/TC Indicator (26, TC) 9 - Not Applicable
Multiple Procedures (51) 9 - Concept does not apply.
Bilateral Surgery (50) 9 - Concept does not apply.
Physician Supervisions 09 - Concept does not apply.
Assistant Surgeon (80, 82) 9 - Concept does not apply.
Co-Surgeons (62) 9 - Concept does not apply.
Team Surgery (66) 9 - Concept does not apply.
Diagnostic Imaging Family 99 - Concept Does Not Apply
APC Status Indicator Conditionally packaged laboratory tests
Type of Service (TOS) 5 - Diagnostic Laboratory
Berenson-Eggers TOS (BETOS) T1H - Lab tests - other (non-Medicare fee schedule)
MUE Not applicable/unspecified.
CCS Clinical Classification 233 - Laboratory - Chemistry and Hematology
Date
Action
Notes
2017-12-31 Deleted Code deleted.
2013-01-01 Changed Description Changed
Pre-1990 Added Code added.
CasePilot

Get instant expert-level medical coding assistance.

Ask about:
CPT Codes Guidelines Modifiers Crosswalks NCCI Edits Compliance Medicare Coverage
Example: "What is CPT code 99213?" or "Guidelines for E/M services"